The dynamics of clot formation in fresh‐frozen plasma
- 5 February 2008
- journal article
- Published by Wiley in Vox Sanguinis
- Vol. 94 (4) , 306-314
- https://doi.org/10.1111/j.1423-0410.2008.01037.x
Abstract
Background Factor VIII (FVIII) levels are used as a quality marker of fresh‐frozen plasma (FFP); however, other clotting factors are not routinely measured. Methods We assessed additional haemostatic parameters and the dynamics of coagulation using Thrombelastography (TEG®) and a thrombin generation test (TGT). FFP was prepared on the day of donation (Day 0) or after overnight hold at 4°C (Day 1). Results Factor VIII in Day 1 FFP was 18% lower than in Day 0. TEG® parameters in Day 1 FFP were consistent with increased coagulability and did not correlate with altered levels of clotting factors, but were consistent with the increased levels of microparticles seen in the Day 1 samples. TGT studies exhibited increased lag time, time to peak and reduced peak thrombin generation, but no change in endogenous thrombin potential (ETP) on Day 1. There was a weak association between FVIII level and both ETP and peak thrombin (ETP rs≥ 0·22, P≤ 0·003; peak thrombin rs≥ 0·48, P≤ 0·0001), which was influenced by ABO group, with the lowest levels in group O. Conclusion We conclude that levels of FVIII do not predict the haemostatic potential of FFP and that there may be a role for alternative technologies in monitoring the quality of FFP.Keywords
This publication has 31 references indexed in Scilit:
- Emerging Technologies and Quality Assurance: The United Kingdom National External Quality Assessment Scheme PerspectiveSeminars in Thrombosis and Hemostasis, 2007
- Platelet and Leukocyte Activation in Salvaged Blood and the Effect of Its Reinfusion on the Circulating BloodClinical Orthopaedics and Related Research, 2007
- Thrombin generation in plasma of healthy adults and children: Chromogenic versus fluorogenic thrombogram analysisThrombosis and Haemostasis, 2007
- The effects of leukodepletion on the generation and removal of microvesicles and prion protein in blood componentsTransfusion, 2006
- Tailoring haemostatic treatment to patient requirements – an update on monitoring haemostatic response using thrombelastographyHaemophilia, 2005
- Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence‐based reviewTransfusion, 2005
- The quality of fresh‐frozen plasma produced from whole blood stored at 4°C overnightTransfusion, 2005
- Variations of factor VIII:C plasma levels with respect to the blood group ABOTransfusion Medicine, 2004
- Coagulation and Chromogenic Assays of Factor VIII Activity: General Aspects, Standardization, and RecommendationsSeminars in Thrombosis and Hemostasis, 2002
- Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptivesBritish Journal of Haematology, 1997